A.Giaccari1 · G. Gliozzo1 · G. Ciccarelli1 · G. Di Giuseppe1 · C. Castellano2 · S. Cum3 · L. Delle Monache4,13 · M. Gallo5 ·M.Lastretti6 · G. Medea7 · M. Monesi8 · R. Napoli9 · B. Pintaudi10 · E. Succurro11 · G. Turchetti
Received: 9 January 2026 / Accepted: 17 March 2026 © The Author(s) 2026
Abstract
Background and aims Although continuous glucose monitoring (CGM) devices are now standard of care among Type 1 diabetes patients, they are still relatively underutilized in Type 2 diabetes (T2D), particularly in those patients not treated with insulin. Widespread adoption continues to be hindered by a combination of factors. Chief among these is the scarcity of long-term, large-scale clinical trials demonstrating the benefits of the use of CGM in T2D. This meta-analysis aimed to address this gap by comparing CGM with self-blood glucose monitoring (SBMG), with primary outcomes of HbA1c and time in range (TIR) in insulin-treated and non-insulin-treated TD2 patients.
Methods and results Following the stringent rules mandated by our National Health Service (which requires a panel com-posed of all stakeholders involved in diabetes treatment, and includes PICO, GRADE, AGREE, and meta-analyses), we performed a systematic review of RCTs that enrolled two groups of individuals with T2D, those treated with insulin (includ-ing basal and basal-bolus regimens), and those receiving treatments other than insulin. All included trials compared CGM with structured blood glucose monitoring (SBGM) with glycated hemoglobin (HbA1c) as the main endpoint. Based on the strength and consistency of the evidence, the panel issued a strong recommendation in favor of CGM for individuals with T2D treated with insulin (including those on basal insulin alone) and for individuals with T2D not treated with insulin, par-ticularly for those with glycated hemoglobin levels≥7%. From a pharmacoeconomic perspective, outcomes were positive in both patient groups.
Conclusion CGM represents a clinically effective and cost-efficient approach to optimizing glycemic control in T2D, becom-ing mandatory among individuals on insulin therapy. Our findings support a shift in clinical practice toward the more widespread use of CGM in T2D, with regulatory frameworks and reimbursement policies needing to adapt accordingly.
Keywords CGM · Type 2 Diabetes · Metanalysis · PICO · GRADE · Guidelines
Communicated by Massimo Federici, M.D.
A. Giaccari 该Email地址已收到反垃圾邮件插件保护。要显示它您需要在浏览器中启用JavaScript。
1 Center for Endocrine and Metabolic Diseases, Fondazione Policlinico Universitario A. Gemelli IRCCS and Università Cattolica del Sacro Cuore, Rome, Italy
2 Azienda USL of Modena, Sassuolo Hospital, Sassuolo, Italy
3 Diabetes and Diabetic Foot Care Unit, ASUGI, Monfalcone, Italy
4 National Board Member of FAND (Italian Association for the Rights of Diabetic People), Roma, Italy
5 Department of Endocrinology and Metabolic Diseases, AO SS. Antonio e Biagio e Cesare Arrigo, Alessandria, Italy
6 Order of Psychologists of Lazio, Rome, Italy
7 Italian Society of General Medicine (SIMG), Florence, Italy
8 Territorial Diabetology Unit, AUSL Ferrara, Ferrara, Italy
9 Department of Translational Medical Sciences, University of Naples Federico II, Naples, Italy
10 Diabetes Unit, Niguarda Cà Granda Hospital, Milan, Italy
11 Department of Medical and Surgical Sciences, Magna Graecia University, Catanzaro, Italy
12 Institute of Management, Scuola Superiore Sant’Anna, Pisa, Italy
13 Patient Advocacy Lab, ALTEMS – Università Cattolica del Sacro Cuore, Rome, Italy
版权归中华医学会所有。
未经授权,不得转载、摘编本刊文章。
引用本文:简喜超, 简扬, 邓呈亮. 2025版《中国糖尿病足防治实践指南》解读[J]. 中华医学美学美容杂志, 2026, 32(2): 99-103. DOI: 10.3760/cma.j.cn114657-20251215-00266.
通信作者:邓呈亮,Email:该Email地址已收到反垃圾邮件插件保护。要显示它您需要在浏览器中启用JavaScript。
中华医学会整形外科学分会中国雄激素性脱发诊断与治疗指南制订工作组整形美容 .专业国家级医疗质量控制中心中国整形美容协会毛发 医学分会中 国女医师协会.整形美容专业委员会通信作者:张菊芳,西湖大学医学院附属杭州市第一人民医院医疗美容科,杭州310006, Email: zhjuf@ vip. sina. com;
吴文育,复旦大学附属华山医院皮肤科,上海200040, Email: wuwenyu@ huashan. org. cn;
牛冬,浙江农林大学动物科技学院、动物医学院,杭州311300, Email: dniu@ zafu. edu.cn;
龙笑,中国医学科学院北京协和医学院北京协和医院整形外科,北京100032, Email: pumclongxiao@ 126. com.
[摘要] 雄激素性脱发发病率逐年增高并呈现低龄化的趋势,困扰着众多患者。对于雄激素性脱发的治疗,近年来出现了很多新方式和思路,因此雄激素性脱发的治疗策略需要随之更新;另外,随着近年来毛发行业的发展,大量的从业者涌人雄激素性脱发诊治的相关岗位,因此需要经过证实的指南来进行指引。指南制订工作组遴选了有关临床问题,经过证据检索、专家论证,形成了相关推荐意见,以期能够进一步规范雄激素性脱发的治疗决策。
[关键词] 脱发;雄激素性脱发; 整形外科;指南基金项目:杭州市医学重点学科( 002020004);上海市级医院皮肤科临床能力促进与提升专科联盟(SHDC22022302);上海市重中之重研究中心建设项目(2023702018);上海毛发医学工程技术研究中心(19D22250500);浙江省自然科学基金重点项目(LZ22C010003);北京协和医院中央高水平医院临床科研专项( 2022-PUMCH-B-042)
DOI: 10. 3760/ema. j. en1 14453-20231029-00156
Chinese guideline for the diagnosis and treatment of androgenetic alopecia ( 2023)
The Working Group of Chinese Guideline for the Diagnosis and Treatment of Androgenetic Alopeeia, Chinese Medical Association of Plastic Surgery; National Medical Quality Control Center for Plastic Surgery; Society of Hair Medicine, Chinese Association of Plastics and Aesthetics; Plastic & Aesthetic Surgery Comitee, China Medical Women 's Association
Corresponding author: Zhang Jufang, Department of Medical Cosmetology, Hangzhou First People' s Hospital, Westlake University, Hangzhou 310006, China, Email: zhjuf@ rip. sina. com; Wu Wenyu,Department of Dermatology, Huashan Hospital, F'udan University, Shanghai 200040, China, Email: wuwenyu@ huashan. org. cn; Niu Dong, Animal Science College and Animal Medicine College , ZhejiangA&F University , Hangzhou 311300,China, Email: dniu@ zafu. edu. cn; Long Xiao, Department of Plastic Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100032, China ,Email: pumclongxiao@ 126. com
[ Summary] The incidence rate of androgenetice alopecia is increasing year by year and presents a trend of younger age, which puzzles many patients. In recent years, there have been many new treatmentmethods and ideas for androgenetic alopecia, so the treatment strategies for androgenetic alopecia need to be : updated accordingly. In addition, with the development of the hair industry in recent years, a large number of practitioners have flocked to positions related to the diagnosis and treatment of androgenetie alopecia, so proven guidelines are needed for guidance. The guide writing team selected relevant clinical issues, gave recommendations based on a thorough literature review of the latest reports and expert' s evaluation, in the hope of providing a treatment algorithm for androgenetic alopecia.
[Key words] Alopecia; Androgenetic alopecia; Plastie surgery; Guideline
Fund program: Hangzhou Key Discipline of Medieine ( 0020200044 ) ; Shanghai M unicipal Hospital Dermatology Clinical Ability Promotion and Enhancement Specialist Alliance .( SHDC22022302) ; Shanghai Most Important Research Center Construction Project ( 2023Z702018) ; Shanghai Hair Medical Engineering Technology Research Center ( 19DZ2250500); Zhejiang ProvinceNatural Science Foundation Key Project ( LZ22C010003 ); National High Level Hospital Clinical Research Funding ( 2022-PUMCH-B-042)
Disclosure of Conflicts of Interest: The authors have no financial interest to declare in relation to the content of this article.
DOI: 10. 3760/ ema. j. en1 14453-2023 1029-00156
何黎1 ,郑捷2 ,马慧群3 ,郝飞4 ,刘玮5 ,王刚6 ,李利7 ,高兴华8 ,项蕾红9 ,吴艳1 0 ,谢红付11 ,袁超12 ,林彤13 ,赖维14 ,刘盛秀1 5 ,张丽8 ,李吉1 1 ,严淑贤9 ,崔勇16 ,李虹17 ,陈抗18 ,周展超19 ,钟莉20 ,梁虹2 1 ,骆丹2 2 ,卢凤艳23 ,熊霞24 ,庞勤2 5 ,王玮蓁26 ,王秀丽12 ,朱丽萍1
[中图分类号] R 593. 1
[文献标识码] A
[文章编号] 1001 - 7089( 2017) 01 - 0001 - 04
[DOI] 10. 13735 /j. cjdv. 1001-7089. 201611168
[基金项目] 云南省“高原皮肤病防治转化医学协同创新中心”( 601160707) ; 教育部 2013 年度“创新团队发展计划”( RIT13067) 资助项目
[作者单位] 1. 昆明医科大学第一附属医院,云南 昆明 650032;
2. 上海交通大学附属瑞金医院,上海 200240;
3. 西安交通大学第二附属医院,陕西西安710000;
4. 第三军医大学第一附属医院( 西南医院) ,重庆400038;
5. 北京空军总医院,北京100142;
6. 第四军医大学西京医院,陕西 西安710000;
7. 四川大学华西医院,四川 成都610041;
8. 中国医科大学附属第一医院,辽宁 沈阳110001;
9. 复旦大学附属华山医院,上海200040;
10. 北京大学第一医院,北京 100034;
11. 中南大学湘雅医院,湖南 长沙 410008;
12. 上海市皮肤病医院,上海 200443;
13. 中国医学科学院皮肤病医院,江苏 南京210042;
14. 中山大学附属第三医院,广东 广州 510630;
15. 安徽医科大学附属医院,安徽 合肥 230032;
16. 中日友好医院,北京 100029;
17. 昆明薇诺娜皮肤医疗美容有限公司,云南 昆明 650031;
18. 海南省皮肤病医院,海南 海口 570000;
19. 南京展超丽格医疗美容诊所,江苏 南京 210000;
20. 重庆大学附属医院,重庆 400038;
21. 武汉大学人民医院,湖北 武汉 430060;
22. 南京医科大学第一附属医院,江苏 南京 210029;
23. 曲靖市第一人民医院,云南 曲靖 655000;
24. 西南医科大学附属中医医院,重庆 400038;
25. 天津市中医药研究院附属医院( 长征医院) ,天津 300120;
26. 武汉市第一医院,湖北 武汉 430070
[学术秘书] 朱丽萍,E-mail: 13529062890@ 103. com
Laurent Misery 1,2 , Catherine Jean-Decoster3 , Sophie Mery 3 , Victor Georgescu 3 and Vincent Sibaud 3 1 Laboratory of Neurosciences of Brest, University of Western Brittany, 2 Department of Dermatology, University Hospital of Brest, Brest, and 3 Dermatological Laboratories Avène, Lavaur, France
Sensitive skin is common but until now there has been no scale for measuring its severity. The Sensitive Scale is a new scale with a 14-item and a 10-item version that was tested in 11 countries in different languages on 2,966 participants. The aim of this study was to validate the pertinence of using the Sensitive Scale to measure the severity of sensitive skin. The internal consistency was high. Correlations with the dry skin type, higher age, female gender, fair phototypes and Dermatology Life Quality Index were found. Using the 10-item version appeared to be preferable because it was quicker and easier to complete, with the same internal consistency and the 4 items that were excluded were very rarely observed in patients. The mean initial scores were around 44/140 and 37/100. The use of a cream for sensitive skin showed the pertinence of the scale before and after treatment. Key words: sensitive skin; DLQI; scale; severity; questionnaire.
Accepted Apr 2, 2014; Epub ahead of print Apr 7, 2014
Acta Derm Venereol 2014; 94: 635–639.
Prof Laurent Misery, Department of Dermatology, University Hospital of Brest, 2 avenue Foch, FR-29200 Brest, France. E-mail: 该Email地址已收到反垃圾邮件插件保护。要显示它您需要在浏览器中启用JavaScript。
© 2014 The Authors. doi: 10.2340/00015555-1870 Journal Compilation © 2014 Acta Dermato-Venereologica. ISSN 0001-5555
保湿润肤类产品应用指导专家共识(2023版)
中国医师协会皮肤科医师分会
通信作者:郝飞,Email:该Email地址已收到反垃圾邮件插件保护。要显示它您需要在浏览器中启用JavaScript。;高兴华,Email:该Email地址已收到反垃圾邮件插件保护。要显示它您需要在浏览器中启用JavaScript。
Guidance on application of moisturizers and emollients: an expert consensus (2023)
China Dermatologist Association
Corresponding authors: Hao Fei, Email: 该Email地址已收到反垃圾邮件插件保护。要显示它您需要在浏览器中启用JavaScript。; Gao Xinghua, Email: 该Email地址已收到反垃圾邮件插件保护。要显示它您需要在浏览器中启用JavaScript。
伤口世界平台生态圈,以“关爱人间所有伤口患者”为愿景,连接、整合和拓展线上和线下的管理慢性伤口的资源,倡导远程、就近和居家管理慢性伤口,解决伤口专家的碎片化时间的价值创造、诊疗经验的裂变复制、和患者的就近、居家和低成本管理慢性伤口的问题。
2019广东省医疗行业协会伤口管理分会年会
扫一扫了解详情:
任何关于疾病的建议都不能替代执业医师的面对面诊断。所有门诊时间仅供参考,最终以医院当日公布为准。
网友、医生言论仅代表其个人观点,不代表本站同意其说法,请谨慎参阅,本站不承担由此引起的法律责任。